Showing results (141-150 of 286) with videos related to

Sort By:
Pageof 29
BMC Cancer|February 26, 2020
Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case reportYuta Adachi, Naohiro Yanagimura, Chiaki Suzuki, et al.
Japanese Journal of Clinical Oncology|November 25, 2025
Waiting periods for the initiation of cancer treatment and the factors associated with delays in the Hokushin region of JapanYutaro Takahashi, Yoshikazu Nishino, Tomoya Takiguchi, et al.
Oncology Reports|January 1, 2014
Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesotheliomaMakio Moriya, Tadaaki Yamada, Masaya Tamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancerIvan S Donev, Wei Wang, Tadaaki Yamada, et al.
The Journal of Medical Investigation : JMI|November 5, 2020
Resminostat, a histone deacetylase inhibitor, circumvents tolerance to EGFR inhibitors in EGFR-mutated lung cancer cells with BIM deletion polymorphismSachiko Arai, Shinji Takeuchi, Koji Fukuda, et al.
Cancer Discovery|May 8, 2016
Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung CancerHidenori Kitai, Hiromichi Ebi, Shuta Tomida, et al.
Cancer Science|June 26, 2003
Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related moleculesSeiji Yano, Hiroshi Nokihara, Akihiko Yamamoto, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2021
Androgen replacement therapy for cancer-related symptoms in male: result of prospective randomized trial (ARTFORM study)Kouji Izumi, Hiroaki Iwamoto, Hiroshi Yaegashi, et al.
Thoracic Cancer|February 7, 2024
Genomic evolutional analysis of surgical resected specimen to assess osimertinib as a first-line therapy in two patients with lung cancer harboring EGFR mutation: Case seriesHayato Koba, Taro Yoneda, Hiroko Morita, et al.
Frontiers in Oncology|July 23, 2024
Challenges in the treatment of <i>BRAF</i> K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinibAkihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, et al.
Pageof 29